HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Jubilant Pharmova's arm to invest 94.5 million Canadian Dollar to double RUBY-FILL capacity
Oct-09-2026

Jubilant Pharmova's step-down subsidiary -- Jubilant Draximage Inc., is planning to invest 94.5 million Canadian Dollar to modernize and expand its Kirkland, Quebec facility and increase production capacity across its radiopharmaceutical portfolio pipeline. Specifically, the investment is aimed to double the production capacity of its flagship product RUBY-FILL. The Government of Canada will provide a financial support of 23.8 million Canadian Dollar to this project. Jubilant Draximage Inc., is a subsidiary of the company’s wholly owned subsidiary Jubilant Pharma.

The business continues to see very strong demand for the RUBY-FILL, the customer base has doubled in the last 3 years. This expansion will allow the company to fulfil the elevated demand.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

  RELATED NEWS >>